The Outcome of Postoperative Radiation Therapy for Patients with Stage II Pancreatic Cancer (T3 or N1 Disease) |
Kim, Sang-Won
(Departments of Radiation Oncology, Ajou University School of Medicine)
Kim, Myung-Wook (Departments of Surgery, Ajou University School of Medicine) Kim, Wook-Hwan (Departments of Surgery, Ajou University School of Medicine) Kang, Seok-Yun (Departments of Internal Medicine, Ajou University School of Medicine) Kang, Seung-Hee (Departments of Radiation Oncology, Ajou University School of Medicine) Oh, Young-Taek (Departments of Radiation Oncology, Ajou University School of Medicine) Lee, Sun-Young (Departments of Radiation Oncology, Ajou University School of Medicine) Yang, Ju-No (Departments of Radiation Oncology, Ajou University School of Medicine) Chun, Mi-Sun (Departments of Radiation Oncology, Ajou University School of Medicine) |
1 | Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999;189:1-7 |
2 | Corsini MM, Miller RC, Haddock MG, et al. Adjuvant radiation and chemotherapy for pancreatic adenocarcinoma: the Mayo clinic experience. 2007 Gastrointestinal cancers symposium |
3 | Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5‐fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776‐784 |
4 | Abrams RA, Grochow LB, Chakaravarthy A, et al. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observation regarding patterns of failure, radiotherapy dose and CA19‐9 levels. Int J Radiat Oncol Biol Phys 1999;44:1039‐1046 |
5 | Van Laethem JL, Demols A, Gay F, et al. Postoperative adjuvant gemcitabine and concurrent radiation therapy after curative resection of pancreatic head carcinoma: a phase II study. Int J Radiat Biol Phys 2003;56:974-980 DOI ScienceOn |
6 | Regine WF, Winter KW, Abrams R, et al. RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5‐FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma. J Clin Oncol (Meeting Abstracts) 2006;24: 4007 |
7 | Blackstock AW, Mornex F, Partensky C, et al. Adjuvant Gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. Br J Cancer 2006;95:260-265 DOI ScienceOn |
8 | Kim K, Kim S, Chie EK, Kim SW, Bang YJ, Ha SW. Postoperative chemoradiotherapy of pancreatic cancer: What is the appropriate target volume of radiation therapy? Tumori 2005;91:493‐497 PUBMED |
9 | Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single0institution experience. Ann Surg 1997;225:621‐633 |
10 | National Statistics Office, Republic of Korea. 2005 Annual report of the cause of death statstics. 2006 |
11 | Demols A, Peters M, Polus M, et al. Adjuvant gemcitabine and concurrent continuous radiation therapy (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian phase II study. Int J Radiat Biol Phys 2005;62:1351-1356 DOI ScienceOn |
12 | Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987; 59:2006‐2010 |
13 | Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899‐903 |
14 | Bakkevold KE, Arnesjo B, Dahl O, et al. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater-Results of a controlled, prospective, randomized multicentre study. Eur J Cancer 1993;29A:698‐703 |
15 | Westerdahl J, Andren‐Sandberg A, Ihse I. Recurrence of exocrine pancreatic cancer‐local or hepatic? Hepatogastroenterology 1993;40:384‐387 |
16 | Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas‐616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;6:567‐579 |
17 | Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210 DOI ScienceOn |
18 | Takada T, Amano H, Yasuda H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter, prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 2002;95:1685‐1695 |
19 | Foo ML, Gunderson LL, Nagorney DM, et al. Pantterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys 1993;26:483‐489 |
20 | Kuhlmann KF, de Castro SM, Wesseling JG, et al. Surgical treatment of pancreatic adenocarcinoma; actuarial survival and prognostic factors in 343 patients. Eur J Cancer 2004;40:549‐558 DOI ScienceOn |